Overview

Study of Albuterol and Oxandrolone in Patients With Facioscapulohumeral Dystrophy (FSHD)

Status:
Completed
Trial end date:
2004-08-01
Target enrollment:
Participant gender:
Summary
This is a study to determine whether albuterol or oxandrolone, alone or in combination, are able to increase strength and muscle mass in patients with FSHD. It also will determine if albuterol given in "pulsed" fashion will have more effect than when given continuously.
Phase:
N/A
Details
Lead Sponsor:
FDA Office of Orphan Products Development
Treatments:
Albuterol
Oxandrolone